Patent Assignment
Reel/Frame 030552/0780
Assignment of Assignor's Interest
Recorded: 2013-06-05
Pages: 3
Assignor
DERVIEUX, THIERRY
Executed: 2013-05-05
Assignee
EXAGEN DIAGNOSTICS, INC.
800 BRADBURY SE, SUITE 108, ALBUQUERQUE, NEW MEXICO, 87106
Covered Property
(1)
Methods for optimizing biological response modifier therapy using therapeutic drug monitoring of immunosuppressants
Application:
13/756,616 →
Publication:
US 2013/0216530
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Short-Form Patent Security Agreement
Oct 15, 2013
From: EXAGEN DIAGNOSTICS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031414/0660 →
Release of Security Interest
Sep 7, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 043784/0828 →